Patents by Inventor Katsunari Tezuka

Katsunari Tezuka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020102658
    Abstract: Immunization of human antibody-producing transgenic mice, which have been created using genetic engineering techniques, with AILIM molecule as an antigen resulted in various human monoclonal antibodies capable of binding to AILIM and capable of controlling a variety of biological reactions (for example, cell proliferation, cytokine production, immune cytolysis, cell death, induction of ADCC, etc.) associated with AILIM-mediated costimulatory signal (secondary signal) transduction. Furthermore, it has been revealed that the human monoclonal antibody is effective to treat and prevent various diseases associated with AILIM-mediated costimulatory signal transduction, being capable of inhibiting the onset and/or advancement of the diseases.
    Type: Application
    Filed: May 16, 2001
    Publication date: August 1, 2002
    Inventors: Takashi Tsuji, Katsunari Tezuka, Nobuaki Hori
  • Patent number: 5132413
    Abstract: A sugar chain of the following formula is disclosed. ##STR1## It can be prepared by separating glycoproteins from cell membrane components by using lectins which recognize the sugar chain, releasing the sugar chain structure from the glycoproteins, and purifying the released sugar chain. The sugar chain is useful for the diagnosis and treatment of cancer.
    Type: Grant
    Filed: September 25, 1990
    Date of Patent: July 21, 1992
    Assignee: Japan Immuno Research Laboratories Co., Ltd.
    Inventors: Akihiro Aizawa, Nobuo Shimoda, Masakazu Adachi, Katsunari Tezuka, Hideko Ishihara, Hiroyuki Hanzawa, Yoji Arata, Noriko Takahashi